Italy· 050971023

MEDEPIDOL*30 cpr 4 mg rilascio prolungato

A medicinal product containing idromorfone, registered in Italy by G.L. PHARMA GmbH, on the national reimbursement list.

Reimbursed in Italy (AIFA class A)

Checked against the register on June 4, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about idromorfoneAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

Active substance: Idromorfone
Manufacturer: G.L. PHARMA GmbH
Country: Italy (IT)
ATC code: —
Reimbursed: Yes
Last checked: June 4, 2026

Packs & prices · 1

1 priced

aic
050971023
MEDEPIDOL*30 cpr 4 mg rilascio prolungato
EUR 15.08

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Idromorfone in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All idromorfone products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

Austria · Hydagelan, Hydal
Belgium · Palladone
Czechia · Palladone
Germany · Dolomorphon, Dolomorphon Akut
Denmark · Hydromorphonhydrochlorid Kalceks, Palladon
Estonia · Hydromorphone Kalceks
Spain · Edunix
Finland · Hydofon, Hydromorphone Kalceks
France · Hydagelan Lp, Sophidone L.P
United Kingdom (Northern Ireland) · Palladone, Palladone-Sr
Ireland · Hydromorphone Hydrochloride Ethypharm, Hydromorphone Kalceks
Liechtenstein · Jurnista
Luxembourg · Hydromorphon Hameln, Palladone
Malta · Hydromorphone Aristo, Hydromorphone Quintian
Netherlands · Hydagelan, Hydromorfonhydrochloride Kalceks
Norway · Hydofon, Hydromorfonhydroklorid Kalceks
Portugal · Edunix, Hidromorfona Aristo
Sweden · Gerodolan, Hydofon
Slovakia · Palladone-Sr Capsules

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/952293ec-10ca-4ace-8cfe-bad4a5be8a22
GET /v1/drugs/952293ec-10ca-4ace-8cfe-bad4a5be8a22?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 15.08,
  "source": "aifa",
  "currency": "EUR",
  "strength": "IDROMORFONE 4 MG 30 UNITA' USO ORALE RP",
  "substance": "Idromorfone",
  "equivalence_group": "NVM",
  "transparency_flag": null
}

API reference MCP server Plans

See everything about idromorfone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console